Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EVERLIGHT AGM Information 2018

Jun 15, 2018

51894_rns_2018-06-15_39316aaa-e3c8-40a2-bb14-d4200b235f0c.pdf

AGM Information

Open in viewer

Opens in your device viewer

Taiwan Stock Code: 1711

Everlight Chemical Industrial Corporation

Handbook for the 2018 Annual General Shareholders’ Meeting

TIME: June 6, 2018

PLACE: Central Pictures Bade Building Auditorium (3F., No.260, Sec. 2, Bade Rd., Taipei City, Taiwan)

DISCLAIMER

THIS IS A TRANSLATION OF THE HANDBOOK FOR THE 2018 ANNUAL GENERAL SHAREHOLDERS’ MEETING (THE “HANDBOOK”) OF EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION.(THE “COMPANY”). THIS TRANSLATION IS INTENDED FOR REFERENCE ONLY AND NOTHING ELSE, THE COMPANY HEREBY DISCLAIMS ANY AND ALL LIABILITIES WHATSOEVER FOR THE TRANSLATION. THE CHINESE TEXT OF THE AGENDA SHALL GOVERN ANY AND ALL MATTERS RELATED TO THE INTERPRETATION OF THE SUBJECT MATTER STATED HEREIN.

Table of Contents

Table of Contents Table of Contents
I. Meeting Agenda……………….................................... P1
1. Report Items………………………..………….....................
P2
2. Adoption Items………………………………...................... P3
3. Election Item……………………………………………….. P5
4. Discussion Items..…………………………………………. P8
5. Questions and Motions…………………………………….. P9
II. Attachments…………………......................................
1. Independent accountants’ audit report and consolidated
financial statements………………………………………...
P10-
P25

Everlight Chemical Industrial Corporation

Agenda of 2018 Annual General Shareholders’ Meeting

Time: 9:00 a.m. on Wednesday, June 6, 2018

Venue: Central Pictures Bade Building Auditorium ( 3F., No.260, Sec. 2, Bade Rd., Taipei City, Taiwan)

1. Report Items

(1) 2017 Business Report

(2) 2017 Audit Committee’s Review Report

  • (3) Report on 2017 employees’ profit sharing bonus and directors’ compensation

  • (4) Report on 2017 the status of implementation of investments

2. Adoption Items

(1) Adoption of the 2017 Business Report and Financial Statements

(2) Adoption of the Proposal for Distribution of 2017 Profits

3. Election Item

To elect eleven Directors(including three independent directors)

4. Discussion Items

To release the newly elected directors from non-competition restrictions

5. Questions and Motions

6. Adjournment

  • 1 -

Report Items

Report No. 1

2017 Business Report, please refer to Chinese version, P.3~P.4 for details.

Report No. 2

Audit Committee’s Review Report

The Board of Directors has prepared the Company’s 2017 Business Report, Financial Statements, and proposal for allocation of earnings, The CPAs, Ms. Lily Lu and Ms. ChunHsiu Kuang, of KPMG Taiwan were retained to audit ECIC’s Financial Statements and have issued an audit report relating to the Financial Statements. The Business Report, Financial Statements, and earnings allocation proposal have been reviewed and determined to be correct and accurate by the Audit Committee members of the Company. According to relevant requirements of the Securities and Exchange Act and the Company Law, we hereby submit this report.

Everlight Chemical Industrial Corporation

Chairman of the Audit Committee: Rebecca Chung-Fern Wu March 29, 2018

Report No. 3

Report on 2017 employees’ profit sharing bonus and directors’ compensation

Items Approved byBOD Note
Employees’profit sharingbonus NT$ 23,356,876 To be distributed in cash.
Directors’ compensation NT$ 9,342,750

Report No. 4

Report on 2017 the status of implementation of investments, please refer to Chinese version, P.7 for details.

  • 2 -

Adoption Items

Item 1. Proposed by the Board of Directors

Proposal:

Adoption of the 2017 Business Report and Financial Statements Explanation:

  • ( 1 ) The Company’s Financial Statements, including the balance sheets, income statements, statements of changes in shareholders’ equity and statements of cash flows, were audited by independent auditors, Ms. Lily Lu and Ms. Chun-Hsiu Kuang of KPMG Taiwan. The Financial Statements described above and the Business Report of 2017 have been authorized by the Board of Directors and examined by the Audit Committee.

  • ( 2 ) The 2017 Financial Statements are attached hereto as Attachments 1 (P.10~P.25).

Resolution:

  • 3 -

Item 2. Proposed by the Board of Directors Proposal:

Adoption of the Proposal for Distribution of 2017 Profits

Explanation:

  • ( 1 ) The proposed earnings distribution is allocated from Earnings in 2017 Available for Distribution. Each common shareholder will be entitled to receive a cash dividend of NT$ 0.5 per share.

  • ( 2 ) Should the total of the Company’s common shares outstanding change for any reason, the ultimate cash dividend to be distributed to each common share may need be adjusted accordingly. It is proposed that the Chairman of Board of Directors of the Company be authorized to adjust that cash dividend to be distributed to each common share based on the total amount of earnings resolved to be distributed and the number of actual common shares outstanding on the record date for distribution.

  • ( 3 ) 2017 Profit Distribution Table is attached hereto as below.

Everlight Chemical Industrial Corporation PROFIT DISTRIBUTION TABLE Year 2017

Year 2017
(Unit: NT$)
Items Subtotal Total
Unappropriated retained earnings at beginning of the year 292,889,001
Profit before tax 434,437,899
Less: Income tax expense 68,299,799
Profit after tax 366,138,100
Add: Remeasurements of defined benefit plan 14,587620
Less: Changes in ownership interests in subsidiaries 4,797,768
Distributable net profit 668,816,953
Distributable items:
Less: 10% legal reserve 36,613810
Cash dividends(NT$ 0.5 per share) 273,876,113
Subtotal 310,489,923
Unappropriated retained earnings at the end of the year 358,327,030

Resolution:

  • 4 -

Election Item

Proposed by the Board of Directors

Proposal:

To elect eleven Directors (including three independent directors)

Explanation:

  • (1) The term of the Company’s current directors will expire by June 10, 2018. In accordance with the Articles of Incorporation, the Board of Directors resolved that eleven Directors (including three independent directors) will be elected at this Annual Shareholders’ Meeting. The tenure of newly elected directors shall commence on June 6, 2018 and expire on June 5, 2021.

  • (2) The directors shall be elected by adopting candidates nomination system as specified in Article 192-1 of the ROC Company Law. The directors shall be elected from the nominated candidates, whose education and professional qualifications, experience and relevant information are attached hereto as below.

Election Results:

List of director candidates
Name Number of
shares held
Education Experience Current position
Chen,Chien-Hsin 6,725,250 Master of Public Health
(MPH), Harvard University
Vice Superintendent, Country
Hospital, Taipei, Taiwan
Chief, Department of Internal
Medicine & ICU, Puli Christian
Special Assistant to Chairman,
Everlight Chemical Industrial Corp.
Vice Chairman of BOD, Everlight
Chemical Industrial Corp.
Chairman of BOD, Everlight
Chemical Industrial Corp.
Chairman of BOD, Everlight
Chemicals (Singapore) PTE LTD.
Chairman of BOD, Trend Tone
Imaging, Inc.
Chairman of BOD, DailyCare
BioMedical Inc.
Chairman of BOD, Keystone
Pharmaceuticals, Inc.
Director, Elite Foreign Trading Inc.
(Turkey)
Director, GOOD TV Broadcasting
Corp.
Chen,Ding-Chuan 81,000,000 B.S. in International Trade,
Tamkang College of Arts
and Sciences
Honorary Doctorate in
Management,Chang Jung
Christian University
Chairman of BOD, Everlight
Chemical Industrial Corp.
Supervisor, Chung Hwa Chemical
Industrial Works, Ltd.
Director, Everlight Chemical
Industrial Corp.
  • 5 -
Chen,Ding-Chi 14,975,254 Doctor of Christian
Education ,Cohen
University
Vice Chairman of BOD, Everlight
Chemical Industrial Corp.
General Manager, Everlight
Chemical Industrial Corp.
Director, GOOD TV Broadcasting
Corp.
Director, Everlight Chemical
Industrial Corp.
Chen,Wei-Wang 6,300,000 Ph.D. in Industrial
Engineering, University of
Michigan
Deputy General Manager, Everlight
Chemical Industrial Corp.
Assistant General Manager ,R&D
Division, Everlight Chemical
Industrial Corp.
Director and General Manager,
Everlight Chemical Industrial Corp.
Chairman of BOD, Everlight
(Suzhou) Advanced Chemicals Ltd.
Chairman of BOD, Everlight U.S.A.
Chairman of BOD, Everlight Europe
B.V. (Netherlands)
Chairman of BOD, Everlight
(Hongkong) Ltd.
Chairman of BOD, Ethical
(Shanghai) Ltd.
Chairman of BOD, Everlight
(Shanghai) Ltd.
Chairman of BOD, Ethical
(Guangzhou) Ltd.
Director, Trend Tone Imaging, Inc.
Director, Polytronics Technology
Corp.
Director, Elite Foreign Trading Inc.
(Turkey)
Director, Anda Semiconductor
Technology (Suzhou) Co., Ltd.
Director, 3E Chemical (Suzhou) Ltd.
Chen,Chien-Ming 3,503,192 Ph.D. in Mechanical
Engineering, University of
Michigan
Senior Project Engineer, General
Motors Corp.
Deputy Director of Supply Chan
Management Division, Everlight
Chemical Industrial Corp.
Deputy General Manager, Trend
Tone Imaging, Inc.
Director, Everlight Chemical
Industrial Corp.
Director, Trend Tone Imaging, Inc.
Director and General Manager,
Everlight U.S.A.
Lee,Yung-Long 2,281,007 B.S. in Public
Administration,National
Chung Hsing University
Chairman of BOD, Hangzhou Yuda
Technology Company
Director, Everlight Chemical
Industrial Corp.
Ken,Wen-Yuen 2,951,405 M.S. in Computer System
Management, University of
San Francisco
Deputy General Manager, Chung
Hwa Chemical Industrial Works, Ltd.
Chairman of BOD and General
Manager, Chung Hwa Chemical
Industrial Works, Ltd.
Director, Everlight Chemical
Industrial Corp.
Director, Honest Fine Chemical Co.,
Ltd.
Tsai,Kuang-Feng 312,636 M.S. in Chemical
Engineering, University of
Southern California
Assistant General Manager,
Marketing Department, Laurel
Industrial Corporation
Assistant General Manager, Everlight
Chemical Industrial Corp.
Deputy General Manager, Everlight
Chemical Industrial Corp.
Director, Everlight Europe B.V.
(Netherlands)
  • 6 -

List of independent director candidates

List of independent director candidates List of independent director candidates List of independent director candidates List of independent director candidates List of independent director candidates
Name Number of
shares held
Education Experience Current position
Wang,Hsiu- Chun 0 Ph.D. in Engineering-
Economic Systems and
Operations, Stanford
University
Managing Director, WK Technology
Fund
Global Head of Semiconductor
Research, ABN AMRO Bank
Yield Improvement Engineer, KLA-
Tencor Corporation
ManagingPartner,ZRC
Managing Partner, GRC SinoGreen
Fund and GVT Fund
Chairman, SinoGreenergy Company
Independent Director, Swancor
Holding Corp.
Independent Director, Everlight
Chemical Industrial Corp.
Hung,Ying-Cheng 0 Ph.D. in Business
Administration, National
Chengchi University
Department director, Department of
Business Administration, Tamkang
University
Associate Professor, Department of
Business Administration, Tamkang
University
Independent Director, Everlight
Chemical Industrial Corp.
Wu,Chung-Fern 0 Ph.D. in Accounting and
Information Management,
UCLA
Independent Director, Chunghwa
Telecom Co., Ltd.
Independent Director, Taiwan Sugar
Corp.
Commissioner, Financial Supervisory
Commission, R.O.C
Assistant Professor, Fisher School of
Accounting, University of Florida
Audit Manager, Taiwan Union CPA
Office
Professor, Department of
Accounting, National Taiwan
University
Director, Taiwan Cooperative
Financial Holding Co., Ltd.
Supervisor, Taiwan Cooperative
Bank, Ltd.
Director, GreTai Securities Market
Independent Director, Chunghwa
Precision Test Tech.Co., Ltd .
Independent Director, Everlight
Chemical Industrial Corp.
  • 7 -

Discussion Items

Proposed by the Board of Directors

Proposal:

To release the newly elected directors from non-competition restrictions

Explanation:

In accordance with the Article 209 of the Company Act, it is proposed to lift the non-competition restrictions to the newly elected directors as below. Resolution:

Title Name CompanyName and Concurrent Positeion
Director Chen,Chien-Hsin Chairman of BOD, Everlight Chemicals (Singapore) PTE LTD.
Chairman of BOD, Trend Tone Imaging, Inc.
Chairman of BOD, DailyCare BioMedical Inc.
Chairman of BOD, Keystone Pharmaceuticals, Inc.
Director, Elite Foreign Trading Inc. (Turkey)
Director,GOOD TV BroadcastingCorp.
Director Chen,Wei-Wang Chairman of BOD, Everlight (Suzhou) Advanced Chemicals Ltd.
Chairman of BOD, Everlight U.S.A.
Chairman of BOD, Everlight Europe B.V. (Netherlands)
Chairman of BOD, Everlight (Hongkong) Ltd.
Chairman of BOD, Ethical (Shanghai) Ltd.
Chairman of BOD, Everlight (Shanghai) Ltd.
Chairman of BOD, Ethical (Guangzhou) Ltd.
Director, Trend Tone Imaging, Inc.
Director, Polytronics Technology Corp.
Director, Elite Foreign Trading Inc. (Turkey)
Director, Anda Semiconductor Technology (Suzhou) Co., Ltd.
Director,3E Chemical(Suzhou)Ltd.
Director Chen,Chien-Ming Director, Trend Tone Imaging, Inc.
Director and General Manager,Everlight U.S.A.
Director Ken,Wen-Yuen Chairman of BOD and General Manager, Chung Hwa Chemical Industrial
Works, Ltd.
Director,Honest Fine Chemical Co.,Ltd.
Director Tsai,Kuang-Feng Director, Everlight Europe B.V. (Netherlands)
  • 8 -
Independent
Director
Wang,Hsiu- Chun Managing Partner, GRC SinoGreen Fund and GVT Fund
Chairman, SinoGreenergy Company
Independent Director,Swancor HoldingCorp.
Independent
Director
Wu,Chung-Fern Director, Taiwan Cooperative Financial Holding Co., Ltd.
Supervisor, Taiwan Cooperative Bank, Ltd.
Director, GreTai Securities Market
Independent Director, Chunghwa Precision Test Tech.Co., Ltd .

Questions and Motions

Adjournment

  • 9 -

Attachments 1

Independent AuditorsReport

To the Board of Directors Everlight Chemical Industrial Corporation:

Opinion

We have audited the consolidated financial statements of Everlight Chemical Industrial Corporation and its subsidiaries (�the Group�), which comprise the consolidated balance sheets as of December 31, 2017 and 2016, and the consolidated statements of comprehensive income, changes in equity and cash flows for the years ended December 31, 2017 and 2016, and notes to the consolidated financial statements, including a summary of significant accounting policies.

In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Group as at December 31, 2017 and 2016, and its consolidated financial performance and its consolidated cash flows for the years then ended in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers and with the International Financial Reporting Standards (�IFRSs�), International Accounting Standards (�IASs�), interpretation as well as related guidance endorsed by the Financial Supervisory Commission of the Republic of China.

Basis for Opinion

We conducted our audit in accordance with the Regulations Governing Auditing and Certification of Financial Statements by Certified Public Accountants and the auditing standards generally accepted in the Republic of China. Our responsibilities under those standards are further described in the Auditors� Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are independent of the Group in accordance with the Certified Public Accountants Code of Professional Ethics in Republic of China (�the Code�), and we have fulfilled our other ethical responsibilities in accordance with the Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis of our opinion.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the consolidated financial statements of the current period. These matters were addressed in the context of our audit of the consolidated financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

  1. Revenue recognition

Please refer to Note 4(n) and Note 6(r) to the consolidated financial statements for the disclosure of revenue recognition.

Description of key audit matters

The Group is a listed Company in related to public interest, and the investors are highly expecting the financial performance, resulting in revenue recognition is one of the key judgmental areas of our audit.

How the matter was addressed in our audit

Our major audit procedures included testing of the design and implement of controls over sales and collection of receivable transactions; evaluate if there is any significant abnormal changes through performing trend analysis on top 10 customers by comparing the related changes or differences; assessing and testing if the management obtained sufficient external evidence showing that the risks and rewards of ownership have been transferred to the customers, to support the timing of revenue recognition; evaluating the adequacy of revenue recognition by testing the sale transactions during the period before and after the balance sheet date.

  • 10 -

2. Valuation of accounts receivable

Please refer to Notes 4(g), 5(a) and 6(c) to the consolidated financial statements for the disclosure of the valuation of accounts receivable.

Description of key audit matters

Given the challenging economic climate, the risk of receivables recovery remains high, resulting in significant judgment being applied in the management's assessment of the recoverability of accounts receivable. Consequently, this is one of the key judgmental areas of our audit.

How the matter was addressed in our audit

Our major audit procedures included testing the adequacy of aging report; evaluating the appropriateness of the provision made by the management through assessing the historical receivables recoverability, customers' industry situation and subsequent recoverability.

  1. Impairment of property, plant and equipment

Please refer to Notes 4(m), 5(b) and 6(g) to the consolidated financial statements for the disclosure of the impairment of property, plant and equipment.

Description of key audit matters

The Group evaluates if there is any indication of impairment of property, plant and equipment and then estimates the recoverable amount of property, plant and equipment in according with value in use. The calculation for recoverable amount involved assumptions and estimations, resulting in impairment of property, plant and equipment is one of the key judgmental areas of our audit.

How the matter was addressed in our audit

Our major audit procedures included obtaining the impairment valuation report of cash generating unit which is identified by the Group; evaluating the appropriateness of the assumptions and estimations, including the future cash flows, discount rate and gross margin and the sensitivity analysis of the related assumptions.

Other Matter

Everlight Chemical Industrial Corporation has prepared its parent-company-only financial statements as of and for the years ended December 31, 2017 and 2016, on which we have issued an unmodified opinion.

Responsibilities of Management and Those Charged with Governance for the Consolidated Financial Statements

Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with Regulations Governing the Preparation of Financial Reports by Securities Issuers and IFRSs, IASs, interpretation as well as related guidance endorsed by the Financial Supervisory Commission of the Republic of China, and for such internal control as management determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, management is responsible for assessing the Group�s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Group or to cease operations, or has no realistic alternative but to do so.

Those charged with governance (including audit committee) are responsible for overseeing the Group�s financial reporting process.

  • 11 -

Auditors Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor�s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with the auditing standards generally accepted in the Republic of China will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements.

As part of an audit in accordance with auditing standards generally accepted in the Republic of China, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

  1. Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

  2. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group�s internal control.

  3. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

  4. Conclude on the appropriateness of management�s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group�s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors� report to the related disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor�s report. However, future events or conditions may cause the Group to cease to continue as a going concern.

  5. Evaluate the overall presentation, structure and content of the consolidated financial statements, including the disclosures, and whether the consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

  6. Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the Group to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision and performance of the group audit.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

  • 12 -

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the consolidated financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditors� report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

The engagement partners on the audit resulting in this independent auditors� report are Lily Lu and Chun-Hsiu Kuang.

KPMG

Taipei, Taiwan (Republic of China) March 29, 2018

Notes to Readers

The accompanying consolidated financial statements are intended only to present the consolidated statement of financial position, financial performance and its cash flows in accordance with the accounting principles and practices generally accepted in the Republic of China and not those of any other jurisdictions. The standards, procedures and practices to audit such consolidated financial statements are those generally accepted and applied in the Republic of China.

The auditors� report and the accompanying consolidated financial statements are the English translation of the Chinese version prepared and used in the Republic of China. If there is any conflict between, or any difference in the interpretation of the English and Chinese language auditors� report and consolidated financial statements, the Chinese version shall prevail.

  • 13 -

(English Translation of Consolidated Financial Statements and Report Originally Issued in Chinese) EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION AND SUBSIDIARIES

Consolidated Balance Sheets

December 31, 2017 and 2016

(Expressed in, New Taiwan Dollars)

Assets
Current assets:
1100
Cash and cash equivalents (note 6(a))
1150
Notes receivable, net (note 6(c))
1170
Accounts receivable, net (note 6(c))
130X
Inventories (note 6(d))
1476
Other current financial assets
1479
Other current assets (note 6(h))
Total current assets
Non-current assets:
1523
Available-for-sale financial assets-non-current (note 6(b))
1543
Financial assets measured at cost (note 6(b))
1550
Investments accounted for using equity method (note 6(e))
1600
Property, plant and equipment (notes 6(g), (k), 8 and 9)
1780
Intangible assets (note 6(i))
1840
Deferred tax assets (note 6(n))
1915
Prepayments for equipment
1980
Other non-current financial assets (note 6(c))
1985
Long-term prepaid rents
1990
Other non-current assets
Total non-current assets
Total assets
December 31, 2017 December 31, 2016
Amount
%
981,138
7
281,186
2
1,459,364
11
3,386,017
25
45,270
-
170,871
1
6,323,846
46
1,069,726
8
128,366
1
76,837
1
5,685,055
42
32,592
-
102,860
1
119,446
1
33,017
-
24,405
-
7,820
-
7,280,124
54
13,603,970
100
Liabilities and Equity
Current liabilities:
2100
Short-term borrowings (notes 6(j) and 9)
2322
Long-term borrowings, current portion (notes 6(g), (k) and 8)
2150
Notes payable
2170
Accounts payable (notes 6(q) and 7)
2209
Other payables
2213
Payables on equipment
2230
Current tax liabilities
2399
Other current liabilities
Total current liabilities
Non-current liabilities:
2540
Long-term borrowings (notes 6(g), (k) and 8)
2570
Deferred tax liabilities (note 6(n))
2640
Net defined benefit liabilities (note 6(m))
Total non-current liabilities
Total liabilities
Equity attributable to owners of parent (notes 6(e), (m), (n), (o) and (t)):
3100
Common share
3200
Capital surplus
3300
Retained earnings
3400
Other equity
Total equity attributable to owners of parent:
36XX
Non-controlling interests (notes 6(f) and (o))
Total equity
Total liabilities and equity
December 31, 2017 December 31, 2016
Amount
%
$ 947,185
7
274,904
2
1,532,710
11
3,392,199
25
17,143
-
137,506
1
Amount
%
Amount
%
$ 2,063,876
15
60,000
-
238,797
2
400,002
3
512,701
4
56,920
1
42,102
-
40,582
-
2,568,900
19
248,540
2

226,829
2

412,578
3

522,633
4

107,772
1
59,180
-
26,652
-
6,301,647
46
1,038,813
7
89,200
1
143,035
1
5,789,476
42
119,020
1
103,989
1
93,632
1
5,480
-
23,524
-
16,802
-
3,414,980
25
4,173,084
31
1,913,228
14
55,064
1
304,568
1
1,052,530
8

53,309
-

344,912
2
2,272,860
16
1,450,751
10
5,687,840
41
5,623,835
41
5,477,522
40
473,558
3
1,673,952
12
99,054
2
5,477,522
40

473,558
3

1,571,900
12

135,428
2
7,422,971
54
7,724,086
57
7,658,408
57
312,692
2
321,727
2
8,036,778
59
7,980,135
59
$
13,724,618
100
$
13,724,618
100
13,603,970
100

See accompanying notes to consolidated financial statements.

  • 14 -

(English Translation of Consolidated Financial Statements and Report Originally Issued in Chinese) EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION AND SUBSIDIARIES

Consolidated Statements of Comprehensive Income

For the years ended December 31, 2017 and 2016

(Expressed in Thousands of New Taiwan Dollars , Except for Earnings Per Common Share)

4000
Operating revenues (note 6(r))
5000
Operating costs (notes 6(d), (g), (i), (l), (m), (q), 7 and 12)
Gross profit from operations
Operating expenses (notes 6(c), (g), (i), (l), (m), (q), 7 and 12):
6100
Selling expenses
6200
Administrative expenses
6300
Research and development expenses
Total operating expenses
Net operating income
Non-operating income and expenses (notes 6(e), (f), (s) and (t)):
7010
Other income
7020
Other gains and losses
7050
Finance costs
7060
Share of losses of associates accounted for using equity method
Total non-operating income and expenses
7900
Income before income tax
7950
Income tax expense (note 6(n))
Net income
8300
Other comprehensive income (loss) (notes 6(e), (f), (m), (n), (o) and (t)):
8310
Items that may not be reclassified subsequently to profit or loss
8311
Remeasurements of defined benefit plans
8349
Income tax benefit (expense) related to items that may not be reclassified subsequently to
profit or loss
Total items that may not be reclassified subsequently to profit or loss
8360
Items that may be reclassified subsequently to profit or loss
8361
Exchange differences on translation of foreign financial statements
8362
Unrealized losses on available-for-sale financial assets
8370
Share of other comprehensive income of associates accounted for using equity method
8399
Income tax benefit related to items that may be reclassified subsequently to profit or loss
Total items that may be reclassified subsequently to profit or loss
8300
Other comprehensive income
8500
Total comprehensive income
Profit attributable to:
8610
Owners of parent
8620
Non-controlling interests
Comprehensive income (loss) attributable to:
8710
Owners of parent
8720
Non-controlling interests
9750
Basic earnings per share (note 6(p))(in New Taiwan Dollars)
9850
Diluted earnings per share (note 6(p))(in New Taiwan Dollars)
2017
Amount
%
$ 9,169,480
100
7,199,208
79
2017
Amount
%
$ 9,169,480
100
7,199,208
79
2017
Amount
%
$ 9,169,480
100
7,199,208
79
2016 2016
Amount
%
9,450,874
100
7,351,972
78
$
1,970,272
21
2,098,902
22
853,830
9
347,459
4
406,564
4
811,989
9
412,750
4
406,724
4
1,607,853
17
1,631,463
17
362,419
4
467,439
5
64,797
1
131,954
1
(71,690)
(1)
(15,088)
-
63,791
1
122,576
1
(60,371)
(1)
(20,701)
-
109,973
1
105,295
1
472,392
5
102,148
1
572,734
6
98,900
1
370,244
4
473,834
5
17,566
-
(2,986)
-
14,580
-
(70,602)
(1)
12,002
-
(58,600)
(1)
(37,777)
-
(5,291)
-
(1,102)
-
-
-
(84,189)
(1)
(59,788)
-
(82)
-
-
-
(44,170)
-
(144,059)
(1)
(29,590)
-
(202,659)
(2)
$ 340,654
4
271,175
3
$ 366,138
4
4,106
-
468,534
5
5,300
-
$ 370,244
4
473,834
5
$ 344,353
4
(3,699)
-
269,561
3
1,614
-
$ 340,654 4 271,175
3
$ 0.67 0.86
$ 0.67 0.85

See accompanying notes to consolidated financial statements.

  • 15 -

(English Translation of Consolidated Financial Statements and Report Originally Issued in Chinese) EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION AND SUBSIDIARIES

Consolidated Statements of Changes in Equity

For the years ended December 31, 2017 and 2016

(Expressed in Thousands of New Taiwan Dollars)

Balance at January 1, 2016
Appropriation and distribution of
retained earnings:
Legal reserve
Cash dividends
Stock dividends
Net income
Other comprehensive income
Total comprehensive income
Balance at December 31, 2016
Appropriation and distribution of
retained earnings:
Legal reserve
Cash dividends
Net income
Other comprehensive income
Total comprehensive income
Changes in ownership interests in
subsidiaries
Balance at December 31, 2017
Equity attributable Equity attributable to owners ofparent to owners ofparent
Non-controll
inginterests
Totalequity
Common
shares
Capital
surplus
Retained earnings Otherequity Total
equity
attributable
to owners of
parent
Exchange
differences
on translation
of foreign
financial
statements
Unrealized
gains
(losses) on
available-for-s
ale financial
assets
Total
Legal
reserve
Special
reserve
Unappropriated
retained
earnings

Total
retained
earnings
$ 5,216,688
473,558
858,401
43,346
781,292
1,683,039
55,060
221,336
276,396
7,649,681
324,283
7,973,964
-
-
56,534
-
(56,534)
-
-
-
-
-
-
-
-
-
-
-
(260,834)
(260,834)
-
-
-
(260,834)
(4,170)
(265,004)
260,834
-
-
-
(260,834)
(260,834)
-
-
-
-
-
-
-
-
-
-
468,534
468,534
-
-
-
468,534
5,300
473,834
-
-
-
-
(58,005)
(58,005)
(81,180)
(59,788)
(140,968)
(198,973)
(3,686)
(202,659)
-
-
-
-
410,529
410,529
(81,180)
(59,788)
(140,968)
269,561
1,614
271,175
5,477,522
473,558
914,935
43,346
613,619
1,571,900
(26,120)
161,548
135,428
7,658,408
321,727
7,980,135
-
-
46,853
-
(46,853)
-
-
-
-
-
-
-
-
-
-
-
(273,876)
(273,876)
-
-
-
(273,876)
(5,626)
(279,502)
-
-
-
-
366,138
366,138
-
-
-
366,138
4,106
370,244
-
-
-
-
14,589
14,589
(31,083)
(5,291)
(36,374)
(21,785)
(7,805)
(29,590)
-
-
-
-
380,727
380,727
(31,083)
(5,291)
(36,374)
344,353
(3,699)
340,654
-
-
-
-
(4,799)
(4,799)
-
-
-
(4,799)
290
(4,509)
$
5,477,522
473,558
961,788
43,346
668,818
1,673,952
(57,203)
156,257
99,054
7,724,086
312,692
8,036,778

See accompanying notes to consolidated financial statements.

  • 16 -

(English Translation of Consolidated Financial Statements and Report Originally Issued in Chinese) EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION AND SUBSIDIARIES

Consolidated Statements of Cash Flows

For the years ended December 31, 2017 and 2016

(Expressed in Thousands of New Taiwan Dollars)

Cash flows from operating activities:
Income before income tax
Adjustments:
Adjustments to reconcile profit:
Depreciation expense
Amortization expense
Provision for allowance of impairment
Net gains on financial assets at fair value through profit or loss
Interest expense
Interest income
Dividend income
Share of losses of associates accounted for using equity method
Losses (gains) on disposal of property, plant and equipment
Gains on disposal of investments
Remeasurement gains on financial assets measured at cost
Property, plant and equipment transferred to expenses
Total adjustments to reconcile profit
Changes in operating assets and liabilities:
Changes in operating assets:
Notes receivable
Accounts receivable and overdue receivable
Inventories
Other current assets
Other current financial assets
Total changes in operating assets
Changes in operating liabilities:
Notes payable
Accounts payable
Other payable
Other current liabilities
Net defined benefit liabilities
Total changes in operating liabilities
Total changes in operating assets and liabilities
Total adjustments
Cash inflow generated from operations
Interest received
Dividends received
Income taxes paid
Net cash flows from operating activities
Cash flows used in investing activities:
Acquisition of financial assets at fair value through profit or loss
Proceeds from disposal of financial assets at fair value through profit or loss
Proceeds from disposal of available-for-sale financial assets
Acquisition of investments accounted for using equity method
Acquisition of property, plant and equipment
Proceeds from disposal of property, plant and equipment
Acquisition of intangible assets
Increase in other non-current financial assets
Decrease (increase) in other non-current assets
Decrease (increase) in prepayments for equipment
Net cash flows used in investing activities
Cash flows used in financing activities:
Increase in short-term borrowings
Decrease in short-term borrowings
Short-term financing
Proceeds from long-term borrowings
Repayments of long-term borrowings
Cash dividends paid
Interest paid
Subsidiaries distributed cash dividends to non-controlling interests
Change in non-controlling interests
Net cash flows used in financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
2017 2016
$ 472,392
593,812
10,765
32,897
(23)
71,690
(5,085)
(59,712)
15,088
(15,500)
(68,962)
(4,853)
-
572,734
567,524
10,554
22,536
(19)
60,371
(4,749)
(59,042)
20,701
1,972
(103,112)
-
667
570,117 517,403
(711)
(83,314)
(14,619)
41,178
24,514
(19,405)
120,336
(224,944)
(12,612)
(14,155)
(32,952) (150,780)
11,968
(11,891)
(2,246)
9,712
(22,780)
29,595
37,207
54,555
10,349
(11,351)
(15,237) 120,355
(48,189) (30,425)
521,928 486,978
994,320
5,095
59,712
(119,439)
1,059,712
4,877
59,042
(139,927)
939,688 983,704
(93,500)
93,523
94,584
(45,000)
(753,814)
31,444
(96,616)
(833)
(7,337)
5,830
(180,000)
180,019
202,343
-
(704,307)
2,277
(8,494)
(600)
7,545
(69,989)
(771,719) (571,206)
6,424,754
(6,918,593)
-
1,500,000
(828,540)
(273,876)
(78,903)
(5,626)
(7,515)
6,927,593
(6,962,310)
2,000
590,000
(486,883)
(260,834)
(62,096)
(4,170)
(3,686)
(188,299) (260,386)
(13,623) 16,467
(33,953)
981,138
168,579
812,559
$
947,185
981,138

See accompanying notes to consolidated financial statements.

  • 17 -

Independent AuditorsReport

To the Board of Directors Everlight Chemical Industrial Corporation:

Opinion

We have audited the financial statements of Everlight Chemical Industrial Corporation(�the Company�), which comprise the balance sheets as of December 31, 2017 and 2016, and the statements of comprehensive income, changes in equity and cash flows for the years ended December 31, 2017 and 2016, and notes to the financial statements, including a summary of significant accounting policies.

In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Company as at December 31, 2017 and 2016, and its financial performance and its cash flows for the years ended December 31, 2017 and 2016 in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers.

Basis for Opinion

We conducted our audit in accordance with the Regulations Governing Auditing and Certification of Financial Statements by Certified Public Accountants and the auditing standards generally accepted in the Republic of China. Our responsibilities under those standards are further described in the Auditors� Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the Certified Public Accountants Code of Professional Ethics in Republic of China (�the Code�), and we have fulfilled our other ethical responsibilities in accordance with the Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis of our opinion.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial statements of the current period. These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

1. Revenue recognition

Please refer to Note 4(n) and Note 6(q) to the parent-company-only financial statements for the disclosures of revenue recognition

Description of key audit matters

The Company is a listed company in related to public interest, and the investors are highly expecting the financial performance, resulting in revenue recognition is one of the key judgmental areas of our audit.

  • 18 -

How the matter was addressed in our audit

Our major audit procedures included testing of the design and implement of controls over sales and collection of receivable transactions; evaluate if there is any significant abnormal changes through performing trend analysis on top 10 customers by comparing the related changes or differences; assessing and testing if the management obtained sufficient external evidence showing that the risks and rewards of ownership have been transferred to the customers, to support the timing of revenue recognition; evaluating the adequacy of revenue recognition by testing the sale transactions during the period before and after the balance sheet date.

2. Valuation of accounts receivable

Please refer to Notes 4(f), 5(a) and 6(c) to the parent-company-only financial statements for the disclosure of valuation of accounts receivable.

Description of key audit matters

Given the challenging economic climate, the risk of receivables recovery remains high, resulting in significant judgment being applied in the management's assessment of the recoverability of accounts receivable. Consequently, this is one of the key judgmental areas of our audit.

How the matter was addressed in our audit

Our major audit procedures included testing the adequacy of aging report; evaluating the appropriateness of the provision made by the management through assessing the historical receivables recoverability, customers' industry situation and subsequent recoverability.

3. Impairment of property, plant and equipment

Refer to Notes 4(m), 5(b) and 6(f) to the parent-company-only financial statements for the disclosure of the impairment of property, plant and equipment.

Description of key audit matters

The Company evaluates if there is any indication of impairment of property, plant and equipment and then estimates the recoverable amount of property, plant and equipment in according with value in use. The calculation for recoverable amount involved assumptions and estimations, resulting in impairment of property, plant and equipment is one of the key judgmental areas of our audit.

How the matter was addressed in our audit

Our major audit procedures included obtaining the impairment valuation report of cash generating unit which is identified by the Company; evaluating the appropriateness of the assumptions and estimations, including the future cash flows, discount rate and gross margin and the sensitivity analysis of the related assumptions.

Responsibilities of Management and Those Charged with Governance for the Parent-Company-Only Financial Statements

Management is responsible for the preparation and fair presentation of the parent-company-only financial statements in accordance with Regulations Governing the Preparation of Financial Reports by Securities Issuers and for such internal control as management determines is necessary to enable the preparation of parent-company-only financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the parent-company-only financial statements, management is responsible for assessing the Company�s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

� Those charged with governance (including audit committee) are responsible for overseeing the Company s financial reporting process.

  • 19 -

Auditors Responsibilities for the Audit of the Parent-Company-Only Financial Statements

Our objectives are to obtain reasonable assurance about whether the parent-company-only financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor�s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with the auditing standards generally accepted in the Republic of China will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these parent-company-only financial statements.

As part of an audit in accordance with auditing standards generally accepted in the Republic of China, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

  1. Identify and assess the risks of material misstatement of the parent-company-only financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

  2. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control.

  3. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

  4. Conclude on the appropriateness of management�s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company�s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors� report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor�s report. However, future events or conditions may cause the Company to cease to continue as a going concern.

  5. Evaluate the overall presentation, structure and content of the parent-company-only financial statements, including the disclosures, and whether the parent-company-only financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

  6. Obtain sufficient appropriate audit evidence regarding the financial information of the investment in other accounted for using the equity method to express an opinion on this parent-company-only financial statements. We are responsible for the direction, supervision and performance of the audit. We remain solely responsible for our audit opinion.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the parent-company-only financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditors� report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

  • 20 -

The engagement partners on the audit resulting in this independent auditors� report are Lily Lu and Chun-Hsiu Kuang.

KPMG

Taipei, Taiwan (Republic of China) March 29, 2018

Notes to Readers

The accompanying financial statements are intended only to present the statement of financial position, financial performance and its cash flows in accordance with the accounting principles and practices generally accepted in the Republic of China and not those of any other jurisdictions. The standards, procedures and practices to audit such financial statements are those generally accepted and applied in the Republic of China.

The auditors� report and the accompanying financial statements are the English translation of the Chinese version prepared and used in the Republic of China. If there is any conflict between, or any difference in the interpretation of the English and Chinese language auditors� report and financial statements, the Chinese version shall prevail.

  • 21 -

(English Translation of Financial Statements and Report Originally Issued in Chinese) EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION

Balance Sheets

December 31, 2017 and 2016

(Expressed in thousands of New Taiwan Dollars)

Assets
Current assets:
1100
Cash and cash equivalents (note 6(a))
1150
Notes receivable, net (note 6(c))
1170
Accounts receivable, net (note 6(c))
1180
Accounts receivable from related parties, net (notes 6(c) and 7)
1210
Other receivable from related parties, net (notes 6(c) and 7)
130X
Inventories (note 6(d))
1476
Other current financial assets
1479
Other current assets (note 6(g))
Total current assets
Non-current assets:
1523
Available-for-sale financial assets-non-current (note 6(b))
1543
Financial assets measured at cost (note 6(b))
1550
Investments accounted for using equity method (note 6(e))
1600
Property, plant and equipment (notes 6(f) and 9)
1780
Intangible assets (note 6(h))
1840
Deferred tax assets (note 6(m))
1915
Prepayments for equipment
1980
Other non-current financial assets (note 6(c))
Total non-current assets
Total assets
December 31, 2017 December 31, 2016
Amount
%
445,858
4
83,601
1
732,390
6
480,767
4
36,982
-
2,279,169
20
37,693
-
139,618
1
4,236,078
36
1,069,726
9
77,800
1
1,940,808
16
4,311,865
36
30,882
-
88,471
1
71,295
1
29,961
-
7,620,808
64
11,856,886
100
Liabilities and Equity
Current liabilities:
2100
Short-term borrowings (notes 6(i) and 9)
2322
Long-term borrowings, current portion (note 6(j))
2150
Notes payable
2170
Accounts payable (note 7)
2209
Other payables (notes 6(p) and 7)
2213
Payables on equipment
2230
Current tax liabilities
2399
Other current liabilities
Total current liabilities
Non-current liabilities:
2540
Long-term borrowings (note 6(j))
2570
Deferred tax liabilities (note 6(m))
2640
Net defined benefit liabilities (note 6(k))
Total non-current liabilities
Total liabilities
Equity (notes 6(e), (l), (m), (n) and (s)):
3100
Common shares
3200
Capital surplus
3300
Retained earnings
3400
Other equity
Total equity
Total liabilities and equity
December 31, 2017 December 31, 2016
Amount
%
$ 522,068
4
83,221
1
811,808
6
584,980
5
3,890
-
2,312,487
19
13,963
-
86,732
1
Amount
%
Amount
%

1,669,445
14
220,000
2

224,122
2

291,653
3

396,669
3
81,191
1
43,853
-
15,968
-
$ 1,374,847
11
10,000
-
236,636
2
295,664
3
398,972
3
39,134
-
36,164
-
30,849
-
4,419,149
36
2,422,266
19
2,942,901
25
1,038,813
8
77,800
1
1,987,342
16
4,469,701
36
116,119
1
94,967
1
73,670
1
2,405
-
1,788,228
15
54,327
-
291,059
2
877,530
7
52,224
-

325,823
3
2,133,614
17
1,255,577
10
4,555,880
36
4,198,478
35
5,477,522
45
473,558
4
1,673,952
14
99,054
1
5,477,522
46

473,558
4

1,571,900
14

135,428
1
7,860,817
64
7,724,086
64
7,658,408
65
$
12,279,966
100
$
12,279,966
100
11,856,886
100

See accompanying notes to financial statements.

  • 22 -

(English Translation of Financial Statements and Report Originally Issued in Chinese) EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION

Statements of Comprehensive Income

For the years ended December 31, 2017 and 2016

(Expressed in Thousands of New Taiwan Dollars , Except for Earnings Per Common Share)

4000
Operating revenues (notes 6(q) and 7)
5000
Operating costs (notes 6(d), (f), (h), (k), (l), (p), 7 and 12)
Gross profit from operations
5910
Less: unrealized gross profit on sales to subsidiaries
Net gross profit from operations
Operating expenses (notes 6(c), (f), (k), (l), (p), 7 and 12):
6100
Selling expenses
6200
Administrative expenses
6300
Research and development expenses
Total operating expenses
Net operating income
Non-operating income and expenses (notes 6(b), (e), (f), (r) and (s)):
7010
Other income
7020
Other gains and losses
7050
Finance costs
7060
Share of profit of subsidiaries and associates accounted for using equity method
Total non-operating income and expenses
7900
Income before income tax
7950
Income tax expense (note 6(m))
Net income
8300
Other comprehensive income (loss) (notes 6(e), (l), (m), (n) and (s)):
8310
Items that may not be reclassified subsequently to profit or loss
8311
Remeasurements of defined benefit plans
8330
Share of other comprehensive income of subsidiaries accounted for using equity method
8349
Income tax benefit (expense) related to items that may not be reclassified subsequently to
profit or loss
Total items that may not be reclassified subsequently to profit or loss
8360
Items that may be reclassified subsequently to profit or loss
8361
Exchange differences on translation of foreign financial statements
8362
Unrealized losses on available-for-sale financial assets
8380
Share of other comprehensive of associates accounted for using equity method
8399
Income tax benefit related to items that may be reclassified subsequently to profit or loss
Total items that may be reclassified subsequently to profit or loss
8300
Other comprehensive income
8500
Total comprehensive income
9750
Basic earnings per share (note 4(m)) (expressed in New Taiwan dollars)
9850
Diluted earnings per share (note 4(m)) (expressed in New Taiwan dollars)
2017
Amount
%
$ 6,833,550
100
5,530,529
81
2017
Amount
%
$ 6,833,550
100
5,530,529
81
2016 2016
Amount
%
6,925,150
100
5,509,732
80
$
1,303,021
19
8,467
-
1,415,418
20
(1,457)
-
1,311,488
19
1,413,961
20
515,589
8
168,269
2
341,777
5
537,776
8
186,158
2
342,078
5
1,025,635
15
1,066,012
15
285,853
4
347,949
5
62,041
1
102,018
2
(46,204)
(1)
30,730
-
61,275
1
150,026
2
(38,005)
-
9,198
-
148,585
2
182,494
3
434,438
6
68,300
1
530,443
8
61,909
1
366,138
5
468,534
7
17,612
-
(29)
-
(2,994)
-
14,589
-
(67,592)
(1)
(1,903)
-
11,490
-
(58,005)
(1)
(29,981)
-
(5,291)
-
(1,102)
-
-
-
(81,098)
(1)
(59,788)
(1)
(82)
-
-
-
(36,374)
-
(140,968)
(2)
(21,785)
-
(198,973)
(3)
$ 344,353
5
269,561
4
$ 0.67 0.86
$ 0.67 0.85

See accompanying notes to financial statements.

  • 23 -

(English Translation of Financial Statements and Report Originally Issued in Chinese) EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION

Statements of Changes in Equity

For the years ended December 31, 2017 and 2016

(Expressed in Thousands of New Taiwan Dollars)

Balance at January 1, 2016
Appropriation and distribution of retained
earnings:
Legal reserve
Cash dividends
Stock dividends
Net income
Other comprehensive income
Total comprehensive income
Balance at December 31, 2016
Appropriation and distribution of retained
earnings:
Legal reserve
Cash dividends
Net income
Other comprehensive income
Total comprehensive income
Changes in ownership interests in
subsidiaries
Balance at December 31, 2017
Common
shares
Capital
surplus
Retained earnings Retained earnings Other equity Total
equity
Exchange
differences
on translation
of foreign
financial
statements
Unrealized

gains
(losses) on
available-for-
sale financial
assets
Total
Legal
reserve
Special
reserve
Unappropriated
retained
earnings

Total
retained
earnings
$ 5,216,688
473,558
858,401
43,346
781,292
1,683,039
55,060
221,336
276,396
7,649,681
-
-
56,534
-
(56,534)
-
-
-
-
-
-
-
-
-
(260,834)
(260,834)
-
-
-
(260,834)
260,834
-
-
-
(260,834)
(260,834)
-
-
-
-
-
-
-
-
468,534
468,534
-
-
-
468,534
-
-
-
-
(58,005)
(58,005)
(81,180)
(59,788)
(140,968)
(198,973)
-
-
-
-
410,529
410,529
(81,180)
(59,788)
(140,968)
269,561
5,477,522
473,558
914,935
43,346
613,619
1,571,900
(26,120)
161,548
135,428
7,658,408
-
-
46,853
-
(46,853)
-
-
-
-
-
-
-
-
-
(273,876)
(273,876)
-
-
-
(273,876)
-
-
-
-
366,138
366,138
-
-
-
366,138
-
-
-
-
14,589
14,589
(31,083)
(5,291)
(36,374)
(21,785)
-
-
-
-
380,727
380,727
(31,083)
(5,291)
(36,374)
344,353
-
-
-
-
(4,799)
(4,799)
-
-
-
(4,799)
$
5,477,522
473,558
961,788
43,346
668,818
1,673,952
(57,203)
156,257
99,054
7,724,086

Note: For the years ended December 31, 2017 and 2016, the Company recognized the directors and supervisors' remuneration amounting to $9,343 and $11,407, respectively, employee's compensation amounting to $23,357 and $28,519, respectively, and the abovementioned amounts have been deducted in the comprehensive income statements for each period.

See accompanying notes to financial statements.

  • 24 -

(English Translation of Financial Statements and Report Originally Issued in Chinese) EVERLIGHT CHEMICAL INDUSTRIAL CORPORATION

Statements of Cash Flows

For the years ended December 31, 2017 and 2016

(Expressed in Thousands of New Taiwan Dollars)

Cash flows from operating activities:
Income before income tax
Adjustments:
Adjustments to reconcile profit:
Depreciation expense
Amortization expense
Provision for allowance of impairment
Net gains on financial assets at fair value through profit or loss
Interest expense
Interest income
Dividend income
Share of profit of subsidiaries and associates accounted for using equity method
Losses on disposal of property, plant and equipment
Gains on disposal of investments
Unrealized (realized) gross profit on sale to subsidiaries
Total adjustments to reconcile profit
Changes in operating assets and liabilities:
Changes in operating assets:
Notes receivable
Accounts receivable and overdue receivable
Accounts receivable from related parties
Other receivable from related parties
Inventories
Other current financial assets
Other current assets
Total changes in operating assets
Changes in operating liabilities:
Notes payable
Accounts payable
Other payable
Other current liabilities
Net defined benefit liabilities
Total changes in operating liabilities
Total changes in operating assets and liabilities
Total adjustments
Cash inflow generated from operations
Interest received
Dividends received
Income taxes paid
Net cash flows from operating activities
Cash flows used in investing activities:
Acquisition of financial assets at fair value through profit or loss
Proceeds from disposal of financial assets at fair value through profit or loss
Proceeds from disposal of available-for-sale financial assets
Acquisition of investments accounted for using equity method
Acquisition of property, plant and equipment
Proceeds from disposal of property, plant and equipment
Decrease (increase) in other receivables due from loans to related parties
Acquisition of intangible assets
Decrease (increase) in other non-current financial assets
Decrease (increase) in prepayments for equipment
Net cash flows used in investing activities
Cash flows used in financing activities:
Increase in short-term borrowings
Decrease in short-term borrowings
Proceeds from long-term borrowings
Repayments of long-term borrowings
Cash dividends paid
Interest paid
Net cash flows from (used in) financing activities
Net increase in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
2017 2016
$ 434,438 530,443
430,891
9,041
22,820
(9)
46,204
(2,329)
(59,712)
(30,730)
127
(68,962)
(8,467)
401,223
8,971
16,195
(19)
38,005
(2,233)
(59,042)
(9,198)
1,082
(103,112)
1,457
338,874 293,329
380
(74,617)
(104,213)
(702)
(33,318)
23,719
53,584
7,165
2,939
43,681
3,685
(161,962)
(23,432)
(17,742)
(135,167) (145,666)
12,514
4,011
4,729
14,881
(17,152)
47,406
4,434
41,031
(1,851)
(10,928)
18,983 80,092
(116,184) (65,574)
222,690 227,755
657,128
2,340
110,028
(78,575)
758,198
2,137
107,304
(78,514)
690,921 789,125
(80,000)
80,009
94,584
(92,000)
(632,090)
1,179
32,230
(94,278)
(66)
(2,375)
(180,000)
180,019
202,343
-
(599,362)
1,055
(32,230)
(7,662)
58
7,296
(692,807) (428,483)
5,193,778
(5,488,375)
1,500,000
(800,000)
(273,876)
(53,431)
6,473,750
(6,433,003)
400,000
(480,000)
(260,834)
(38,163)
78,096 (338,250)
76,210
445,858
22,392
423,466
$
522,068
445,858

See accompanying notes to financial statements.

  • 25 -